Paper1233232
Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses.
Eichelbaum M and 4 others. Eur J Clin Pharmacol, 1975. Cited by 215 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Papers, record 1233232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1233232
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbamazepine | Major topic |
| Drug Administration Schedule | |
| Epoxy Compounds | |
| Half-Life | |
| Humans | |
| Kinetics | |
| Male | |
| Middle Aged |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,652,110 | Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. | J Pharm Sci | 1968 | https://conductscience.org/library/papers/5652110 | PubMed |
| 2 | 971,704 | Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy. | Eur J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/971704 | PubMed |
| 3 | 4,207,990 | Carbamazepine for epilepsy. A controlled prospective evaluation. | Neurology | 1974 | https://conductscience.org/library/papers/4207990 | PubMed |
| 4 | 5,044,818 | Mass spectrometric characterization of carbamazepine-10,11-epoxide, a carbamazepine metabolite isolated from human urine. | J Pharm Sci | 1972 | https://conductscience.org/library/papers/5044818 | PubMed |
| 5 | 5,884,654 | Blood levels of drug at the equilibrium state after multiple dosing. | Nature | 1965 | https://conductscience.org/library/papers/5884654 | PubMed |
| 6 | 5,015,597 | Carbamazepine in the treatment of tabetic lightning pains. | Arch Neurol | 1972 | https://conductscience.org/library/papers/5015597 | PubMed |
| 7 | 4,521,093 | Concentration of carbamazepine (Tegretol) in serum and in cerebrospinal fluid in patients with epilepsy. | Epilepsia | 1973 | https://conductscience.org/library/papers/4521093 | PubMed |
| 8 | 4,580,994 | Quantitative determination of carbamazepine in plasma by mass fragmentography. | Clin Pharmacol Ther | 1973 | https://conductscience.org/library/papers/4580994 | PubMed |
| 9 | 1,117,034 | Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatography. | J Chromatogr | 1975 | https://conductscience.org/library/papers/1117034 | PubMed |
| 10 | 4,773,786 | Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy. | Acta Neurol Scand | 1973 | https://conductscience.org/library/papers/4773786 | PubMed |
| 11 | 4,804,149 | A micromethod for the determination of carbamazepine in blood by high speed liquid chromatography. | Z Klin Chem Klin Biochem | 1973 | https://conductscience.org/library/papers/4804149 | PubMed |
| 12 | 1,233,212 | Distribution and elimination kinetics of carbamazepine in man. | Eur J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/1233212 | PubMed |
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 215 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,316,811 | Establishing Clinically Relevant Specifications for Carbamazepine Tablets Using Physiologically Based Pharmacokinetic Modeling. | AAPS J | 2025 | https://conductscience.org/library/papers/40316811 | PubMed |
| 39,846,525 | ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children. | Pediatr Rep | 2025 | https://conductscience.org/library/papers/39846525 | PubMed |
| 36,114,834 | Use of a long-acting substitute in detoxification from benzodiazepines: safety (accumulation) problems and proposed mitigation procedure. | Eur J Clin Pharmacol | 2022 | https://conductscience.org/library/papers/36114834 | PubMed |
| 28,064,419 | Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children. | Eur J Drug Metab Pharmacokinet | 2017 | https://conductscience.org/library/papers/28064419 | PubMed |
| 25,982,590 | Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy. | Epilepsia | 2015 | https://conductscience.org/library/papers/25982590 | PubMed |
| 24,312,049 | Effects of antiepileptic drugs on hippocampal neurons coupled to micro-electrode arrays. | Front Neuroeng | 2013 | https://conductscience.org/library/papers/24312049 | PubMed |
| 23,252,947 | Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. | Pharmacogenomics | 2013 | https://conductscience.org/library/papers/23252947 | PubMed |
| 23,096,427 | Enhanced clearance of carbamazepine using albumin-containing dialysate during CVVHDF. | Intensive Care Med | 2013 | https://conductscience.org/library/papers/23096427 | PubMed |
| 22,278,332 | Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22278332 | PubMed |
| 21,107,923 | Diseases affecting bone quality: beyond osteoporosis. | Clin Orthop Relat Res | 2011 | https://conductscience.org/library/papers/21107923 | PubMed |
| 19,566,114 | Characterization of the time course of carbamazepine deinduction by an enzyme turnover model. | Clin Pharmacokinet | 2009 | https://conductscience.org/library/papers/19566114 | PubMed |
| 17,532,712 | Simulated fluctuations in plasma drug concentrations for patients receiving oxcarbazepine or carbamazepine extended-release capsules. | Clin Drug Investig | 2005 | https://conductscience.org/library/papers/17532712 | PubMed |
| 14,754,583 | Incorporating children's toxicokinetics into a risk framework. | Environ Health Perspect | 2004 | https://conductscience.org/library/papers/14754583 | PubMed |
| 9,114,913 | Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/9114913 | PubMed |
| 8,877,250 | Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8877250 | PubMed |
| 8,853,934 | Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8853934 | PubMed |
| 8,471,190 | Carbamazepine overdose. Features of 33 cases. | Drug Saf | 1993 | https://conductscience.org/library/papers/8471190 | PubMed |
| 7,875,188 | Early stage autoinduction of carbamazepine metabolism in humans. | Eur J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7875188 | PubMed |
| 7,248,139 | Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7248139 | PubMed |
| 7,082,531 | Saliva carbamazepine levels in children before and during multiple dosing. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7082531 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1233232
GET https://conductscience.org/api/papers/v1/1233232/cited_by?page=2